Cargando…
The effect of preoperative short-term octreotide treatment to surgery in thyrotropin-secreting pituitary adenomas: a retrospective cohort study
BACKGROUND: To prevent thyroid storm and ensure surgical safety, it is imperative to regulate excessive thyroid hormone levels in patients with thyrotropin-secreting pituitary adenomas (TSHoma) prior to surgery. Somatostatin analogues (SSAs), such as octreotide, have showed efficacy in shrinking tum...
Autores principales: | Zhao, Runsheng, Fan, Kaiyu, Wan, Weiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433543/ https://www.ncbi.nlm.nih.gov/pubmed/37587420 http://dx.doi.org/10.1186/s12902-023-01398-z |
Ejemplares similares
-
Short-term Preoperative Octreotide for Thyrotropin-secreting Pituitary Adenoma
por: Fang, Hong-Juan, et al.
Publicado: (2017) -
Successful management of octreotide-insensitive thyrotropin-secreting pituitary adenoma with bromocriptine and surgery: A case report and literature review
por: Yang, Chengxian, et al.
Publicado: (2017) -
Successful management of octreotide-insensitive thyrotropin-secreting pituitary adenoma with bromocriptine and surgery: A case report and literature review: Erratum
Publicado: (2017) -
Cost-effectiveness of direct surgery versus preoperative octreotide therapy for growth-hormone secreting pituitary adenomas
por: Caulley, Lisa, et al.
Publicado: (2022) -
Thyrotropin-Secreting Pituitary Adenoma Successfully Treated With Cabergoline
por: Saand, Aisha R, et al.
Publicado: (2021)